These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36143203)

  • 1. DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave
    Bajaj A; Blum K; Bowirrat A; Gupta A; Baron D; Fugel D; Nicholson A; Fitch T; Downs BW; Bagchi D; Dennen CA; Badgaiyan RD
    J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.
    Gupta A; Bowirrat A; Gomez LL; Baron D; Elman I; Giordano J; Jalali R; Badgaiyan RD; Modestino EJ; Gold MS; Braverman ER; Bajaj A; Blum K
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?
    Blum K; Gold M; Modestino EJ; Baron D; Boyett B; Siwicki D; Lott L; Podesta A; Roy AK; Hauser M; Downs BW; Badgaiyan RD
    J Syst Integr Neurosci; 2018 May; 4():. PubMed ID: 31750006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
    Blum K; Kazmi S; Modestino EJ; Downs BW; Bagchi D; Baron D; McLaughlin T; Green R; Jalali R; Thanos PK; Elman I; Badgaiyan RD; Bowirrat A; Gold MS
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Mor: Can Induction of Dopamine Homeostasis Along with Electrotherapy Attenuate the Opioid Crisis?
    Blum K; Bowirrat A; Braverman ER; Dennen C; Zeine F; Jafari N; Sunder K; Thanos PK; Baron D; Barh D; Gupta A; Bagchi D; Gold MS; Badgaiyan RD
    Clin Exp Psychol; 2023 Mar; 9(2):1-3. PubMed ID: 37363693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?
    Madigan MA; Gupta A; Bowirrat A; Baron D; Badgaiyan RD; Elman I; Dennen CA; Braverman ER; Gold MS; Blum K
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35681980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
    Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
    Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
    Blum K; Steinberg B; Gondre-Lewis MC; Baron D; Modestino EJ; Badgaiyan RD; Downs BW; Bagchi D; Brewer R; McLaughlin T; Bowirrat A; Gold M
    Psychol Res Behav Manag; 2021; 14():2115-2134. PubMed ID: 34949945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
    Dennen CA; Blum K; Bowirrat A; Thanos PK; Elman I; Ceccanti M; Badgaiyan RD; McLaughlin T; Gupta A; Bajaj A; Baron D; Downs BW; Bagchi D; Gold MS
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
    Blum K; Raza A; Schultz T; Jalali R; Green R; Brewer R; Thanos PK; McLaughlin T; Baron D; Bowirrat A; Elman I; Downs BW; Bagchi D; Badgaiyan RD
    Acta Sci Neurol; 2021 Feb; 4(2):17-24. PubMed ID: 33681869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
    Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
    Blum K; Bowirrat A; Baron D; Lott L; Ponce JV; Brewer R; Siwicki D; Boyett B; Gondre-Lewis MC; Smith DE; Panayotis K T; Badgaiyan S; Hauser M; Fried L; A R; Downs BW; Badgaiyan RD
    J Syst Integr Neurosci; 2020 Aug; 6(2):. PubMed ID: 33614164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis.
    Blum K; Modestino EJ; Neary J; Gondré-Lewis MC; Siwicki D; Moran M; Hauser M; Braverman ER; Baron D; Steinberg B; Laughlin TM; Badgaiyan RD
    Biomed J Sci Tech Res; 2018 Jan; 2(2):1-4. PubMed ID: 30370423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
    Gilley ED; Bowirrat A; Gupta A; Giordano J; A Dennen C; R Braverman E; D Badgaiyan R; McLaughlin T; Baron D; Blum K
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37102488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development.
    Blum K; Bowirrat A; Gondre Lewis MC; Simpatico TA; Ceccanti M; Steinberg B; Modestino EJ; Thanos PK; Baron D; McLaughlin T; Brewer R; Badgaiyan RD; Ponce JV; Lott L; Gold MS
    Curr Psychopharmacol; 2021 Feb; 10():. PubMed ID: 34707969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
    Blum K; Ashford JW; Kateb B; Sipple D; Braverman E; Dennen CA; Baron D; Badgaiyan R; Elman I; Cadet JL; Thanos PK; Hanna C; Bowirrat A; Modestino EJ; Yamamoto V; Gupta A; McLaughlin T; Makale M; Gold MS
    J Neurol Sci; 2023 Oct; 453():120809. PubMed ID: 37774561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-Induced Hyperalgesia.
    Brewer R; Blum K; Bowirrat A; Modestino EJ; Baron D; Badgaiyan RD; Moran M; Boyett B; Gold MS
    Curr Psychopharmacol; 2020; 9(3):164-184. PubMed ID: 37361136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.